Supplementary Figure S1 from Inhibition of Prostate Cancer Osteoblastic Progression with VEGF&lt;sub&gt;121&lt;/sub&gt;/rGel, a Single Agent Targeting Osteoblasts, Osteoclasts, and Tumor Neovasculature